These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27505874)

  • 41. JAAD Grand Rounds. Stellate-shaped ulcers and violaceous plaques.
    Abraham A; Mockler D; Cohen J; Silverstein D
    J Am Acad Dermatol; 2013 Aug; 69(2):324-6. PubMed ID: 23866876
    [No Abstract]   [Full Text] [Related]  

  • 42. Catastrophic calciphylaxis in a patient with lupus nephritis and recent onset of end-stage renal disease.
    Al Beladi FI
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):323-7. PubMed ID: 20228522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calciphylaxis.
    Alspaugh CD; McDonald L; Alspaugh JA
    J Tenn Med Assoc; 1995 Oct; 88(10):397-8. PubMed ID: 7475016
    [No Abstract]   [Full Text] [Related]  

  • 44. LDL-apheresis dramatically improves generalized calciphylaxis in a patient undergoing hemodialysis.
    Iwagami M; Mochida Y; Ishioka K; Oka M; Moriya H; Ohtake T; Hidaka S; Kobayashi S
    Clin Nephrol; 2014 Mar; 81(3):198-202. PubMed ID: 23036228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Calciphylaxis in chronic renal failure].
    González Parra E; Alberola ML; Alcázar R; de la Piedra C; Barat A; Caramelo C
    Rev Clin Esp; 1993 Jun; 193(1):17-9. PubMed ID: 8337454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcific uremic arteriolopathy (calciphylaxis): an evolving entity?
    Llach F
    Am J Kidney Dis; 1998 Sep; 32(3):514-8. PubMed ID: 9740172
    [No Abstract]   [Full Text] [Related]  

  • 47. Calciphylaxis involving both the upper and lower extremities.
    Ozer T; Borazan A; Hosnuter M; Kargi E; Savranlar A; Yilmaz A
    Acta Medica (Hradec Kralove); 2004; 47(4):277-9. PubMed ID: 15841909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relapsing calciphylaxis in a young obese patient hemo-dialyzed in a 3- x 8-hour schedule with a favorable outcome after switching to a 6- x 4-hour schedule.
    Jean G; Vanel T; Terrat JC; Hurot JM; Lorriaux C; Chazot C
    Clin Nephrol; 2008 Jul; 70(1):87-8. PubMed ID: 18793557
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical Images: Acquired perforating dermatosis: association with diabetes and renal failure.
    Lynde CB; Pratt MD
    CMAJ; 2009 Oct; 181(9):615. PubMed ID: 19687103
    [No Abstract]   [Full Text] [Related]  

  • 50. [Calciphylaxis: an uncertain pathogenesis and controversial treatment].
    Marrón B; Coronel F; López-Bran E; Barrientos A
    Nefrologia; 2001; 21(6):596-600. PubMed ID: 11881431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unilateral calciphylaxis in a patient with systemic lupus erythematosus, chronic kidney disease, and hemodialysis-associated steal syndrome.
    Onofiok E; Sivamani RK; Barr KL
    Dermatol Online J; 2011 Sep; 17(9):3. PubMed ID: 21971268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calciphylaxis in moderate renal insufficiency: changing disease concepts.
    Smiley CM; Hanlon SU; Michel DM
    Am J Nephrol; 2000; 20(4):324-8. PubMed ID: 10970987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Warfarin, calciphylaxis, atrial fibrillation, and patients on dialysis: outlier subsets and practice guidelines.
    Eiser AR
    Am J Med; 2014 Apr; 127(4):253-4. PubMed ID: 24333618
    [No Abstract]   [Full Text] [Related]  

  • 54. [Disseminated skin ulcerations associated with chronic renal failure].
    Weckesser S; Goebel H; Donauer J; Schempp CM
    Hautarzt; 2007 Jun; 58(6):538-40. PubMed ID: 17077932
    [No Abstract]   [Full Text] [Related]  

  • 55. Calciphylaxis: a severe complication of the cardiometabolic syndrome in patients receiving hemodialysis.
    Verdalles U; Cueva Pde L; Verde E; Vinuesa SG; Goicoechea M; Mosse A; Lopez-Gomez JM; Luño J
    J Cardiometab Syndr; 2008; 3(1):63-7. PubMed ID: 18326975
    [No Abstract]   [Full Text] [Related]  

  • 56. Calciphylaxis in chronic renal failure.
    Suárez Fernández R; del Cerro M; Herrera M; Sánchez Yus E
    J Eur Acad Dermatol Venereol; 1998 May; 10(3):277-8. PubMed ID: 9643339
    [No Abstract]   [Full Text] [Related]  

  • 57. [A case of calciphylaxis in chronic renal failure].
    Watanabe M; Yamaguchi S; Osanai H; Murakami M
    Hinyokika Kiyo; 2010 Oct; 56(10):597-600. PubMed ID: 21063168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calciphylaxis responsive to lanthanum carbonate (FOSRENOL) therapy.
    Chan MR; Yevzlin AS; Hinshaw M; Jaffery JB
    WMJ; 2008 Nov; 107(7):335-8. PubMed ID: 19180873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcific uremic arteriolopathy in hemodialyzed patients.
    Checheriţă IA; Smarandache D; Rădulescu D; Peride I; Bratu O; Ciocâlteu A; Sebe I; Lascăr I
    Chirurgia (Bucur); 2013; 108(5):736-40. PubMed ID: 24157123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dermoscopic features in two cases of acroangiodermatitis.
    Dabas G; De D; Handa S; Chatterjee D
    Australas J Dermatol; 2018 Nov; 59(4):e290-e291. PubMed ID: 29672824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.